Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

The co-receptor CD36 as a target in regulation of subretinal inflammation

Samy Omri; Katia Melal; Houda Tahiri; Dilan Mulumba; William Lubell; huy ong; Sylvain Chemtob

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):983.

ARVO Annual Meeting Abstract July 2018

IL-1 receptor modulators protect against oxygen-induced retinopathy

Colin Wayne Howe Cheng; Azade Geranurimi; José Carlos Rivera; Isabelle Lahaie; Christiane Quiniou; William Lubell; Sylvain Chemtob

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5332.

ARVO Annual Meeting Abstract September 2016

CD36 receptor modulator as potential drug candidates for the treatment of age-related macular degeneration

Samy Omri; Houda Tahiri; Katia Mellal; william lubell; huy ong; Sylvain Chemtob

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):775.

ARVO Annual Meeting Abstract June 2015

Discovery of novel CD36 receptor modulators as potential drug candidates for choroidal neovascularization.

Samy Omri; Katia Mellal; William Lubell; Huy Ong; Sylvain Chemtob

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):147.

ARVO Annual Meeting Abstract April 2011

Cd36 Is Involved In Sub-retinal Deposits In Age-related Retinal Degeneration

Emilie Picard; Marianne Houssier; Allison Dorfman; Julie Racine; William Lubell; Pierre Lachapelle; Huy Ong; Florian Sennlaub; Sylvain Chemtob

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3914.

Advertisement